MFC Logo

Our Mission

Investigations

Ovulation Induction

IVF

Potential Donors

Our team

Success rates

Fees

International Patients

Contact us

Home

French

 
 
 

 

 
IVF BANNER

IVF

ICSI

Blastocyst Transfer

Assisted Hatching

Frozen Embryos

Egg Donation

 

IN VITRO FERTILIZATION (IVF)

 

Introduction

In vitro fertilization (IVF) is the most sophisticated form of infertility An early embryotreatment. It has been used for over 25 years and in this period of time it has evolved to a relatively simple and very successful treatment option. IVF treatment is offered to patients with damaged fallopian tubes, unexplained infertility where other forms of treatment have failed, and in combination with ICSI (intracytoplasmic sperm insertion) for patients with male factor infertility. It may also be offered to women with diminished ovarian reserve or poor egg quality.

 

Prior to deciding on IVF treatment you will meet your physician and nurse who will explain in detail the steps involved in your treatment. You will be given ample time to reflect and thereafter, at a separate meeting, you will be given an opportunity to sign consent forms for your treatment. You will then meet with a nurse who will teach you how to self-administer injections. She will also give you a detailed plan of your treatment.

 

If at any time during your treatment you have any questions, please do not hesitate to contact us immediately. Our role is to make your treatment non-stressful and successful.

IVF treatment consists of hormonal suppression, ovulation induction, egg collection, embryo transfer and hormonal support following embryo transfer.

[Back to top]

Hormonal suppression
During the IVF process it is essential for a patient not to Four cell embyoovulate prior to egg collection. To prevent this from happening we either suppress your natural cycle with a GnRH agonist before beginning ovarian stimulation ("long protocol"), or alternatively we use a GnRH antagonist after we have begun ovarian stimulation ("short protocol"). In general, we prefer to use the long protocol with a GnRH agonist in women who are young and are expected to have a large number of eggs. In contrast, we prefer to use the short protocol with a GnRH antagonist in women who may not have such a robust response to ovarian stimulation.

If you are on a long IVF protocol, i.e. a GnRH agonist, you will begin daily buserelin injections starting 7 days prior to your expected menstruation. In general you will continue with these injections alone for about 2-3 weeks prior to your baseline down-regulation ultrasound scan. These injections are generally well tolerated. On occasion, patients may have side effects such as headaches, hot flashes, bloating, vaginal dryness or mood swings.

The purpose of your baseline down-regulation scan after 2-3 weeks of the Buserelin is to exclude the presence of ovarian cysts and to verify that your uterine lining is thin. If you have ovarian cysts or your lining is thick your treatment with Buserelin may be continued for another week. If, however, your baseline scan is normal then the dose of Buserelin will be decreased and you will start the ovulation induction phase of the treatment.

[Back to top]

Ovarian stimulation

In IVF treatment ovarian stimulation is achieved with injections of Eight cell embriogonadotropins, e.g. follicle stimulating hormone (FSH). Gonadotropins stimulate and support follicle development within the ovary.  The dose of gonadotropins we will use depends on your age, hormonal profile and ovarian reserve. Typically, you will be on FSH injections for about 10 days before you are ready for your egg retrieval. The first several days of gonadotropin administration are usually free of symptoms. However, after about 7 days some patients experience low abdominal tenderness and bloating.

 

During the time your ovaries are being stimulated you will be closely monitored with ultrasound scans. At each ultrasound scan we will count the number of follicles you have and measure their size. We may also make adjustments to your dose of gonadotropins to avoid over or under stimulation of the ovaries.

 

Once you have a sufficient number of follicles above 17-18mm in diameter we will schedule your egg retrieval. In the evening you will be given an injection of hCG to promote the final maturation of your eggs, and your egg retrieval will be scheduled exactly 36 hours after that hCG injection.  

[Back to top]

Egg Retrieval

This is a very interesting procedure that rarely causes more than mild discomfort. The night before the procedure you will be prescribed an anti-anxiety medication called Ativan. This pill will help you to have a good night sleep and feel relaxed during the procedure. You will be instructed not to eat or drink anything from midnight, and to arrive at the Montreal Fertility Centre one hour prior to the egg retrieval. On your arrival you will be shown to your pre-operative room, and a nurse will take your vital signs and start an intravenous. You will then be escorted to the procedure room where a local anesthetic (freezing) is injected into the skin of your vagina. Additionally, short-acting intravenous medications will be given for sedation and pain relief.

 

Your partner is encouraged to be with you during the egg retrieval. You can bring your favorite CD or tape with you. The egg retrieval is performed by a physician with an ultrasound guided needle puncture through the vaginal wall. As each follicle is punctured, the fluid is drained and examined under a microscope. You will be able to see on one monitor how the physician is emptying your follicles, and on another monitor connected to embryologist s microscope, you will be able to see the eggs. Not every follicle contains an egg. At the Montreal Fertility Centre, eggs are collected from approximately 90% of aspirated follicles. You will know the total number of eggs retrieved prior to leaving. You will also receive your first dose of supplemental progesterone before leaving.

 

Following the egg collection you will be monitored for 1-2 hours before returning home. Do not plan any other activities for the day of your egg retrieval. When you arrive home relax and have an early night. It is not uncommon for women to feel abdominal discomfort and have vaginal soreness and bleeding the evening of the procedure.

[Back to top]

Fertilization and Embryo Transfer

Sperm is prepared and mixed with eggs several hours after Embrio transferyour egg retrieval. Thereafter the sperm and eggs are left in an incubator overnight to allow fertilization to occur. We will call you the day following egg retrieval to inform you as to how many eggs have fertilized. We will then call you each subsequent day until your embryos are ready for transfer to the uterus. You will be ready for your embryo transfer either 3 or 5 days after your egg retrieval. The decision is based on both the number and the quality of embryos obtained. Basically, if you have many high quality embryos to choose from we may elect to grow the embryos for 5 days and perform a blastocyst transfer. On the other hand, if the number of high quality embryo is limited we may transfer them 3 days after you egg retrieval.

 

Embryos are transferred to the uterus using a fine plastic tube (transfer catheter) and ultrasound guidance. This procedure takes only a few minutes and is usually not uncomfortable.

[Back to top]

Luteal Phase and Pregnancy
You will be encouraged to limit your activity for 24-48 hours Fetusafter the embryo transfer. Your activity can then be gradually increased over the next few days. Many women return to work after a few days if their jobs are not stressful, whereas others prefer to take this time off to rest.

Two weeks after your egg retrieval we will ask you to return to the Montreal Fertility Centre for a pregnancy blood test. If your pregnancy test is positive you will be encouraged to continue progesterone supplementation for another 6-7 weeks. An ultrasound scan is done approximately four weeks after your egg retrieval and may be repeated two to three times throughout the first trimester, after which you will be returned to your referring physician for the remainder of your obstetric care.

[Back to top]

Intracytoplasmic Sperm Injection (ICSI)

This technique is reserved for patients with male factor Hatched embryonfertility, those who have already had multiple unsuccessful attempts with intrauterine insemination, or had poor fertilization in previous attempts with IVF. In this technique an embryologist, using specialized glass needle, injects eggs obtained by the IVF process with spermatozoa. This process allows for successful fertilization even in patients who have very few spermatozoa in the ejaculate. The likelihood of achieving a pregnancy following an ICSI procedure is similar to that achieved in an IVF procedure. There is no evidence that ICSI increases the chances of malformations or birth defects. However, in a small percentage of cases, men with severe sperm problems may pass along the same problem to their sons.

[Back to top]

Blastocyst Culture

Patients who develop multiple good quality embryos may be Blastocysteadvised to have their embryos cultured until day five. By day five only the strongest embryos will develop to a blastocyst stage. A blastocyst is an embryo that looks like a transparent hollow ball and contains over 100 cells. Patients who have a transfer of one or more blastocysts have a very high chance of achieving a pregnancy.

[Back to top]

Assisted hatching

This is a process where the shell around the embryo, also called the Hatched embryozona pellucida, is weakened by a laser beam. This allows the embryo to exit its shell more easily and enhances implantation. Assisted hatching does not damage embryos, and some studies have suggested that assisted hatching increases pregnancy rate in patients who are 38 years or older, patients whose embryos have a particularly thick zona pelucida and patients who are transferring frozen-thawed embryos. Assisted hatching is carried out immediately before embryo transfer. 

[Back to top]

Cryopreservation of embryos and Frozen embryo transfer (FET)

Embryos can be frozen at any time, i.e. immediately after fertilization, 3 days after egg retrieval or at the blastocyst stage. We generally prefer to freeze high quality embryos at the blastocyst stage.

 

The day of the freeze and the day of the thaw are critical to the embryos viability. In contrast, the quality of frozen embryos is generally not affected by the length of time that they are cryopreserved.

 

Typically, 60-70% of embryos survive the freeze-thaw process. Frozen embryo transfer (FET) is a relatively simple treatment that involves taking estrogen supplementation alone for about 12-14 days, followed by the addition of progesterone supplementation. The uterine lining is closely monitored and when the lining is sufficiently prepared the embryo transfer is arranged. 

[Back to top]

Egg donation

Egg donation may be the only treatment option for patients with an Mother and babyinsufficient number of eggs available in the ovaries. This poor ovarian reserve could be the result of previous radiation or chemotherapy, pelvic surgery, endometriosis or genetic disorders. It could also simply be the result of ageing. Egg donation is generally the treatment of choice for older women or those who have poor egg quality.

 

Eggs can be donated by intellectually mature women between19 and 35 years of age. Egg donors generally undergo hormonal suppression with a long protocol and ovarian stimulation plus egg retrieval as described above. At the same time, the recipient of the egg donation cycle will have her menstrual cycle synchronized to that of the donor, and will have her uterine lining prepared to receive the embryos after the egg retrieval.

 

In general, the chance of pregnancy with egg donation is related to the age of the egg donor, not the age of the egg recipient. Similarly, in pregnancy the chance of chromosomal abnormalities and miscarriage more closely reflect the age of the egg donor than the age of the pregnant recipient.

[Back to top]

 
OUR MISSION  | INVESTIGATIONS | OV. INDUCTION | IVF | DONORS | OUR TEAM | SUCCESS RATES | FEES | INT. PATIENTS | CONTACT US | HOME